Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1. - Wikidata - wikimedia - TriplyDB

Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1.

Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1.

http://www.wikidata.org/entity/Q35754650

about

Molecular composition and ultrastructure of the caveolar coat complex Caveolin-1 in the regulation of cell metabolism: a cancer perspective The cell biology of fat expansion Caveolin-1 deficiency leads to increased susceptibility to cell death and fibrosis in white adipose tissue: characterization of a lipodystrophic model Cavin-3 dictates the balance between ERK and Akt signaling.Dynamic caveolae exclude bulk membrane proteins and are required for sorting of excess glycosphingolipids.Impact of the loss of caveolin-1 on lung mass and cholesterol metabolism in mice with and without the lysosomal cholesterol transporter, Niemann-Pick type C1.Caveolin-1: An Oxidative Stress-Related Target for Cancer Prevention.Mitochondria-localized caveolin in adaptation to cellular stress and injury.Regulation of intracellular signaling and function by caveolin.Pulmonary hypertension and metabolic syndrome: Possible connection, PPARγ and Caveolin-1 Adiponectin is essential for lipid homeostasis and survival under insulin deficiency and promotes β-cell regeneration Caveolin-1 expression and cavin stability regulate caveolae dynamics in adipocyte lipid store fluctuation A Novel Pathway that Links Caveolin-1 Down-Regulation to BRCA1 Dysfunction in Serous Epithelial Ovarian Cancer Cells.Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism Sex-dependent expression of caveolin 1 in response to sex steroid hormones is closely associated with development of obesity in rats Arterial dysfunction but maintained systemic blood pressure in cavin-1-deficient mice.Caveolins in cardioprotection - translatability and mechanisms Region-specific variation in the properties of skeletal adipocytes reveals regulated and constitutive marrow adipose tissues.Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury.Mitochondrial dysfunction in white adipose tissue.Caveolin1 protects against diet induced hepatic lipid accumulation in mice.Dermal Adipocytes: From Irrelevance to Metabolic Targets?Differential effects of leptin on adiponectin expression with weight gain versus obesity.Metabolic inflexibility: when mitochondrial indecision leads to metabolic gridlock.Deletion of cavin genes reveals tissue-specific mechanisms for morphogenesis of endothelial caveolae.AGPAT2 is essential for postnatal development and maintenance of white and brown adipose tissue.Prohibitin/annexin 2 interaction regulates fatty acid transport in adipose tissue Intermittent hypoxia exacerbates pancreatic β-cell dysfunction in a mouse model of diabetes mellitus Caveolin 1 Modulates Aldosterone-Mediated Pathways of Glucose and Lipid Homeostasis.Caveolin-1 is a critical determinant of autophagy, metabolic switching, and oxidative stress in vascular endothelium.Dissociation of hyperglycemia from altered vascular contraction and relaxation mechanisms in caveolin-1 null mice Differential transendothelial transport of adiponectin complexes.Pleiotropic effects of cavin-1 deficiency on lipid metabolism.Adiponectin inhibits tumor necrosis factor-α-induced vascular inflammatory response via caveolin-mediated ceramidase recruitment and activation.Improved methodologies for the study of adipose biology: insights gained and opportunities ahead.Intestinal epithelial cell caveolin 1 regulates fatty acid and lipoprotein cholesterol plasma levels.From embryonic development to human diseases: The functional role of caveolae/caveolin.Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis.Regulation of adiponectin multimerization, signaling and function.

P2860

Q24323250-B58AEEFA-A0BB-42F8-AF4D-38625A309861 Q28072525-7FF47858-E482-4463-884A-86FF1F01AE0F Q28084054-DB3CAED3-3603-4EAB-87D1-A6AE2A503FBC Q28587658-9675B469-C653-4105-A085-AE75BA7A6D8E Q29347262-CFA7C384-B04F-4C09-A110-30569208F557 Q30643751-86ED1D49-0FB7-4900-8C7A-A529EAF49DB7 Q33669553-2E33B102-49CD-4D4A-A4B9-A17D012EDF1D Q33701745-CB2C299C-AEC3-4962-B65C-71530B7C3850 Q33729738-5CBF7E38-9D47-4671-AE55-C790546F5246 Q34072649-9F2E00BA-0C6A-4E72-9AE3-C74E8352366C Q34178976-68A9619B-76EB-4130-8BBB-C6D945C58456 Q34492575-2C953662-C806-4850-A763-D93CCCDEA0B1 Q34545546-582E4575-F891-4C81-B00F-FD53D66F29CA Q34939445-90148279-C981-4DC7-8663-21FD6575AE8D Q35087570-F1CC9EE6-EF54-40DD-8F17-C8A3F249EB56 Q35114438-83E8FD4C-E611-4899-A1A0-C9DF4E89DAD7 Q35128253-51FED14E-FF5D-4498-AF2D-6665FC10F9F4 Q35286413-5C448669-11BF-4174-B6B2-8A75C1E4C750 Q35932989-68A0701F-3204-44BA-84A0-60B61DE50481 Q36077685-87512F53-DD6A-44BB-A8F0-92C5DA463B64 Q36198938-3FC0400C-F63C-4496-A25D-2D09EBB50CD2 Q36389411-DA414AD7-1308-4A5E-BFF0-6573D74A8C36 Q36421885-56397D7D-DDFF-46B0-B6D7-137434EDB048 Q36563737-C655C5C2-FEA5-423D-AFF6-A24760DB79BC Q36612399-6E8B51BD-EEC3-47A0-AD21-BECFDF8A025C Q36906745-4377A6F1-2A83-4BAD-A3E4-82A85279A300 Q37039780-1E7D5FE5-1AA1-44AE-85EF-FE97AF4E3814 Q37123620-FEA7F7F6-80DE-4854-9398-B25CA8962D77 Q37301887-E3A968AB-1965-4EE5-ABC1-331A33F31C53 Q37434620-19B5D889-FF82-469C-AD35-E1FDD820286B Q37549109-98119E24-5D1D-4D3C-B8B8-B478A8775BBA Q37550688-DD66E948-6ACE-4437-BE31-E192C24B4D8E Q37599498-EE2DABA7-05F2-419F-A28F-4D627519FFA6 Q37653304-5A507B12-0B44-43B4-8ED6-A9E9FDA53653 Q37653646-9BBDDF98-CE71-4B49-9AED-7F9205B5B733 Q37665422-A329A6AE-3E50-490B-A8A6-80FFC8215ACA Q37731174-EE8B7DDF-29C4-4107-A373-1E67596F1156 Q37735126-DB01F9AE-D418-4CC3-87B9-82F4A84013D6 Q38073225-8AD483B4-47BD-4C63-8A6F-A154B5B371F1 Q38177920-B60182BD-4EAC-4B8D-969C-3CC360BDB8B6

P2860

Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1.

http://www.wikidata.org/entity/Q35754650

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Altered mitochondrial function ...... iated with loss of caveolin-1.

@ast

Altered mitochondrial function ...... iated with loss of caveolin-1.

@en

type

label

Altered mitochondrial function ...... iated with loss of caveolin-1.

@ast

Altered mitochondrial function ...... iated with loss of caveolin-1.

@en

prefLabel

Altered mitochondrial function ...... iated with loss of caveolin-1.

@ast

Altered mitochondrial function ...... iated with loss of caveolin-1.

@en

P1433

Q35754650-05DB6B27-C84A-43B2-BA69-C1AD3531F37D

P1476

Q35754650-80F0CCEC-B1EE-4E52-9D42-2F52B4930CB6

P2093

Q35754650-1AA95572-E424-4889-80CB-F2C243059910

Q35754650-1EB55BFD-7FDC-4A3B-BF12-129AD23E0C7C

Q35754650-261E9F8B-8BF6-478B-AC4C-FD04A8C4D520

Q35754650-8CB24C40-A9BE-41AE-A80A-8009EEF20420

Q35754650-8E82728A-CE62-4720-B6FC-956645AAF2C9

P2860

Q35754650-02C473D7-5CEB-440D-94A9-CE82D46330A8

Q35754650-0664EE05-FB00-4C39-8509-2903F6C42E27

Q35754650-07A8B3C4-C291-43A9-8081-33A655702C33

Q35754650-1903D773-5412-4C1E-BD9A-BC60199BF959

Q35754650-1D41DD38-90E1-4C42-99AF-A60B1706DF57

Q35754650-25C93979-078B-43A6-8215-3D3B771CE733

Q35754650-2A8C1C93-5CB4-4D2A-9BA5-03606C1251D8

Q35754650-2D935EA6-B243-42B8-8846-19FAA8EF3B7F

Q35754650-3634558D-9DFF-4D1A-B29F-246FF6358564

Q35754650-36B111CF-EEC5-4E69-B029-EAFDD66DA298

P304

Q35754650-BF6A082E-50D8-420C-B297-8A42276F00FE

P31

Q35754650-120FE19B-FFCB-42C8-9A38-F831D946A148

P356

Q35754650-4783C6B7-7179-4051-93F9-564406320B36

P433

Q35754650-48AB3336-A272-4848-BBBD-FB3D7EAD653F

P478

Q35754650-3A67C19C-C9C3-49F7-914A-CA2CC9402B23

P577

Q35754650-1B3411F8-372D-4FFE-8D93-7E8981236D4C

P5875

Q35754650-8DC33F10-F736-404B-A7ED-4E84DF07E5B2

P698

Q35754650-F617273E-06FC-4F3B-A4DA-CD89FC445E32

P932

Q35754650-2B38C1A8-95BE-41CA-A2A4-D7E6EC02BD7E

P356

J.CMET.2012.01.004

P1433

Cell Metabolism

P1476

Altered mitochondrial function ...... iated with loss of caveolin-1.

@en

P2093

Dorothy I Mundy

http://www.w3.org/2001/XMLSchema#string

Ingrid Wernstedt Asterholm

http://www.w3.org/2001/XMLSchema#string

Jian Weng

http://www.w3.org/2001/XMLSchema#string

Philipp E Scherer

http://www.w3.org/2001/XMLSchema#string

Richard G W Anderson

http://www.w3.org/2001/XMLSchema#string

P2860

Oxidative stress and covalent modification of protein with bioactive aldehydes

A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance

Predominant expression of the mitochondrial dicarboxylate carrier in white adipose tissue

A novel serum protein similar to C1q, produced exclusively in adipocytes

Caveolin-1(-/-)- and caveolin-2(-/-)-deficient mice both display numerous skeletal muscle abnormalities, with tubular aggregate formation

Beta(1)/beta(2)/beta(3)-adrenoceptor knockout mice are obese and cold-sensitive but have normal lipolytic responses to fasting

Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice

Topology of superoxide production from different sites in the mitochondrial electron transport chain

Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in mice.

Enhanced metabolic flexibility associated with elevated adiponectin levels.

P304

171-185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CMET.2012.01.004

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221824659

http://www.w3.org/2001/XMLSchema#string

P698

22326219

http://www.w3.org/2001/XMLSchema#string

P932

3278712

http://www.w3.org/2001/XMLSchema#string